A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients.

[1]  M. Srinivasan,et al.  The Oregon Health Plan: predictors of office-based diabetic quality of care. , 2001, Diabetes care.

[2]  A. Heinemann,et al.  Functional Status and quality-of-life measures. , 2000 .

[3]  M. Saul,et al.  The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. , 1998, Journal of the American Society of Nephrology : JASN.

[4]  P. Eggers,et al.  Development of an end-stage renal disease managed care demonstration. , 1997, Advances in renal replacement therapy.

[5]  T. Steinman.  Managed care, capitation, and the future of nephrology. , 1997, Journal of the American Society of Nephrology : JASN.

[6]  T. Bodenheimer.  The Oregon Health Plan--lessons for the nation. Second of two parts. , 1997, The New England journal of medicine.

[7]  H. Ar.  The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. , 1997 .

[8]  David C. Murray,et al.  Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. , 1996, Kidney international.

[9]  R. Wolfe,et al.  Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis. , 1995, Journal of the American Society of Nephrology : JASN.

[10]  W. Keane,et al.  Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  S H Kaplan,et al.  Principles and practice of case mix adjustment: applications to end-stage renal disease. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E G Lowrie,et al.  The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.

[13]  A. Nissenson,et al.  Variation in end-stage renal disease patient outcomes: what we know, what should we know, and how do we find it out? , 1993, Journal of the American Society of Nephrology : JASN.

[14]  P. Impicciatore,et al.  Effect of coexistent diseases on survival of patients undergoing dialysis. , 1992, ASAIO journal.

[15]  A. Pesce,et al.  Continuous quality improvement in chronic disease: a computerized medical record enables description of a severity index to evaluate outcomes in end-stage renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  W. McClellan,et al.  Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. , 1991, Journal of clinical epidemiology.

[17]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[18]  T. Hutchinson,et al.  Comparing survival of patients on dialysis and after renal transplantation: the effect of the met od of statistical analysis on results , 1985 .

[19]  M. Shwartz,et al.  Severity analysis in end-stage renal disease: a risk group approach , 1985 .

[20]  P. Sanders,et al.  Hemodialysis without anticoagulation. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  P. Salisbury,et al.  Physiological mechanisms which explain the effects of venoarterial pumping and of left ventricular bypass in experimental heart failure. , 1960, Transactions - American Society for Artificial Internal Organs.